Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 248

    FDA approves magnetic device system for sentinel biopsies in breast cancer

    FDA approves magnetic device system for sentinel biopsies in breast cancer

    Ruby Khatun Khatun29 July 2018 10:45 AM IST
    The U.S. Food and Drug Administration (FDA) approved a magnetic device system for guiding lymph node biopsies in patients with breast cancer...
    Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

    Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

    Ruby Khatun Khatun29 July 2018 10:30 AM IST
    New Delhi: Drug firm Sanofi India reported a 35.14 percent rise in its net profit to Rs 99.6 crore for the second quarter ended June 30, 2018.The...
    Alembic Pharma Q1 net profit up 36 percent at Rs 90 crore

    Alembic Pharma Q1 net profit up 36 percent at Rs 90 crore

    Ruby Khatun Khatun29 July 2018 10:15 AM IST
    New Delhi: Drug firm Alembic Pharmaceuticals reported a 35.69 percent rise in its consolidated net profit to Rs 90.47 crore for the quarter ended June...
    AstraZeneca says second quarter earnings dropped 27 percent

    AstraZeneca says second quarter earnings dropped 27 percent

    Ruby Khatun Khatun29 July 2018 9:45 AM IST
    LONDON: Anglo-Swedish drugmaker AstraZeneca says second-quarter earnings dropped 27 percent as it shifted away from dependence on its former...
    GSKs new R&D head bets on genetics with 300 million dollars 23andMe deal

    GSK's new R&D head bets on genetics with 300 million dollars 23andMe deal

    Ruby Khatun Khatun29 July 2018 9:30 AM IST
    LONDON: GlaxoSmithKline's new research boss aims to turbo-charge the British group's drug discovery engine with a $300 million bet on genetics by...
    Sanofi Pasteur launches first Four-Strain Influenza Vaccine in India

    Sanofi Pasteur launches first Four-Strain Influenza Vaccine in India

    Ruby Khatun Khatun28 July 2018 11:00 AM IST
    Kolkata: Sanofi Pasteur, the vaccine division of Sanofi, announced the launch of its 4-strain influenza vaccine FluQuadri in India.FluQuadri will be...
    USFDA inspects Dahej facility, no observations issued: Ajanta Pharma

    USFDA inspects Dahej facility, no observations issued: Ajanta Pharma

    Ruby Khatun Khatun28 July 2018 10:45 AM IST
    New Delhi: Drug firm Ajanta Pharma said the US health regulator has not made any observations after completion of inspection of its Dahej facility in...
    Dr Reddys Labs Q1 net profit increases nearly eight-fold to Rs 456 crore

    Dr Reddy's Labs Q1 net profit increases nearly eight-fold to Rs 456 crore

    Ruby Khatun Khatun28 July 2018 10:30 AM IST
    Hyderabad: Pharma major Dr Reddy's Laboratories reported a nearly eight-fold jump in consolidated profit after tax to Rs 456.1 crore for the first...
    Biocon Q1 net profit up 47 percent to Rs 120 crore

    Biocon Q1 net profit up 47 percent to Rs 120 crore

    Ruby Khatun Khatun28 July 2018 10:15 AM IST
    New Delhi: Biotechnology major Biocon reported a 47 percent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 2018 on...
    Blue Star Engineering wins order worth Rs 100 crore for supply of 28 Medical CT scanners from UPMHS

    Blue Star Engineering wins order worth Rs 100 crore for supply of 28 Medical CT scanners from UPMHS

    Ruby Khatun Khatun28 July 2018 9:45 AM IST
    Mumbai: Air conditioning and commercial refrigeration major, Blue Star said that its wholly owned subsidiary, Blue Star Engineering & Electronics,...
    Bristol-Myers to get negative CHMP opinion on renal cancer drugs

    Bristol-Myers to get negative CHMP opinion on renal cancer drugs

    Ruby Khatun Khatun28 July 2018 9:30 AM IST
    NEW YORK: Bristol-Myers Squibb Co said it was told by European regulators that they will recommend against approving the company’s drugs Opdivo and...
    Dr Reddys launches Hervycta to treat cancer in India

    Dr Reddy's launches Hervycta to treat cancer in India

    Ruby Khatun Khatun27 July 2018 10:30 AM IST
    New Delhi: Drug major Dr Reddy's Laboratories (DRL) announced the launch of Hervycta, indicated for the treatment of certain types of cancer, in...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok